Enablex (Warner Chilcott (US), LLC)


Welcome to the PulseAid listing for the Enablex drug offered from Warner Chilcott (US), LLC. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Warner Chilcott (US), LLC
NON-PROPRIETARY NAME: darifenacin
SUBSTANCE NAME: DARIFENACIN HYDROBROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-12-22
END MARKETING DATE: 0000-00-00


Enablex HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEnablex from Warner Chilcott (US), LLC
LABELER NAME: Warner Chilcott (US), LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/1)
START MARKETING DATE: 2004-12-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0430-0170_b7d38a35-dc1c-4bdc-a32f-776289dc4158
PRODUCT NDC: 0430-0170
APPLICATION NUMBER: NDA021513

Other DARIFENACIN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Darifenacin
Aurobindo Pharma LimitedDarifenacin
AvKARE, Inc.Darifenacin Hydrobromide
Cipla USA Inc.Darifenacin
Golden State Medical Supply, Inc.Darifenacin Hydrobromide
Jubilant Cadista Pharmaceuticals Inc.darifenacin
Macleods Pharmaceuticals LimitedDarifenacin
Par PharmaceuticalDarifenacin Hydrobromide
Torrent Pharmaceuticals LimitedDarifenacin
Warner Chilcott (US), LLCEnablex